Mobile Spirometer Measures Lung Function Between Physician Visits
By HospiMedica International staff writers Posted on 16 Jun 2015 |

Image: The Cohero Health mobile spirometer (Photo courtesy of Cohero Health).
A handheld, wireless spirometer enables in-home tracking and monitoring of asthma and chronic obstructive pulmonary disease (COPD).
The Cohero Health mobile spirometer assesses critical lung function metrics as precisely as clinical-grade spirometers, including peak flow, forced vital capacity (FVC), and forced expiratory volume (FEV1), thus providing a much more accurate picture of lung health. The mobile spirometer is paired via Bluetooth with a smartphone or tablet, enabling real-time measurement and reporting via the AsthmaHero and BreatheSmart applications. The data can be integrated into clinical workflows, to empower decision making at point of care, or as a long-term patient monitoring tool.
The apps can also deliver customized medication reminders and check medication compliance via proprietary HeroTracker sensors. They can thus track and analyze the effects on lung function of maintenance and rescue medication use, along with external triggers. In conjunction with the mobile spirometer, the integrated, connected healthcare platform can help improve clinical decision making and prevent acute events. The mobile spirometer is a product of Cohero Health (New York, NY, USA).
“We are enhancing respiratory care by recording critical measurements over time, outside of a physician’s office,” said Melissa Manice, PhD, MPH, co-founder and CEO of Cohero Health. “This longitudinal view of changes in lung function over time, in parallel with medication adherence tracking, equips physicians to partner with their patient to make more informed treatment decisions together.”
“The inclusion of a mobile spirometer in our platform allows stakeholders to track, for the first time ever, how patients are using their medication, and how they are responding to their medication, in real time,” added Daniel Weinstein, co-founder and COO of Cohero Health. “Through robust tracking, motivating better behaviors, and early identification of potential acute events, the Cohero Health platform enables better patient management, reduced costs to the healthcare system, and most importantly, healthier patients.”
Related Links:
Cohero Health
The Cohero Health mobile spirometer assesses critical lung function metrics as precisely as clinical-grade spirometers, including peak flow, forced vital capacity (FVC), and forced expiratory volume (FEV1), thus providing a much more accurate picture of lung health. The mobile spirometer is paired via Bluetooth with a smartphone or tablet, enabling real-time measurement and reporting via the AsthmaHero and BreatheSmart applications. The data can be integrated into clinical workflows, to empower decision making at point of care, or as a long-term patient monitoring tool.
The apps can also deliver customized medication reminders and check medication compliance via proprietary HeroTracker sensors. They can thus track and analyze the effects on lung function of maintenance and rescue medication use, along with external triggers. In conjunction with the mobile spirometer, the integrated, connected healthcare platform can help improve clinical decision making and prevent acute events. The mobile spirometer is a product of Cohero Health (New York, NY, USA).
“We are enhancing respiratory care by recording critical measurements over time, outside of a physician’s office,” said Melissa Manice, PhD, MPH, co-founder and CEO of Cohero Health. “This longitudinal view of changes in lung function over time, in parallel with medication adherence tracking, equips physicians to partner with their patient to make more informed treatment decisions together.”
“The inclusion of a mobile spirometer in our platform allows stakeholders to track, for the first time ever, how patients are using their medication, and how they are responding to their medication, in real time,” added Daniel Weinstein, co-founder and COO of Cohero Health. “Through robust tracking, motivating better behaviors, and early identification of potential acute events, the Cohero Health platform enables better patient management, reduced costs to the healthcare system, and most importantly, healthier patients.”
Related Links:
Cohero Health
Latest Critical Care News
- Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
- Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
- Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
- Generative AI Technology Detects Heart Disease Earlier Than Conventional Methods
- Wearable Technology Predicts Cardiovascular Risk by Continuously Monitoring Heart Rate Recovery
- Wearable Health Monitoring Device Measures Gases Emitted from and Absorbed by Skin
- Groundbreaking Technology Rapidly Detects Airborne Influenza Viruses
- Handheld Device Could Transform Heart Disease Screening
- Flexible Semi-Autonomous Robot Could Deliver Medicine Inside Body
- Neurorestorative Treatment Strategies Hold Promise for Most Severe Forms of Epilepsy
- Gene Discovery Could Help Grow New Heart Arteries
- Study Discovers Invisible Transmission of Common Hospital-Associated Infection
- Non-Invasive Neuro-Ophthalmology Techniques Could Detect Brain Tumors Earlier
- Mass Manufactured Nanoparticles to Deliver Cancer Drugs Directly to Tumors
- World’s Smallest Pacemaker Fits Inside Syringe Tip
- AI-Powered, Internet-Connected Medical Devices to Revolutionize Healthcare, Finds Study
Channels
Surgical Techniques
view channel
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more